Professor Stefano Molica

Consultant in Haematology, Department Haematology, Castle Hill Hospital, Hull

Role at Hull York Medical School

Current scholarly collaborations include ongoing research initiatives primarily addressing surrogate endpoints in chronic lymphocytic leukemia (CLL) (TTNT, MRD, PFS2) and the use of targeted agents in the treatment of these patients.

Additionally, he is developing pragmatic clinical models to assess frailty and comorbidity burdens in elderly individuals with CLL, with an emphasis on translational applicability to routine practice.

Under the affiliation of Hull York Medical School, Dr. Molica has authored more than 45 PubMed-indexed articles in the past three years, in close collaboration with David Allsup, full Professor of Haematology at HYMS.

Biography
  • MD and haematology specialisation, University of Rome.
  • From 2001–2019 chaired the Hematol Dept at Catanzaro General Hospital (Italy).
  • Consultant in Haematol at Castle Hill Hospital, Hull (2022–23).
  • Internationally recognized CLL expert (298 peer reviewed publications).
  • H index 50 as of Oct 15, 2025.
  • Ranked 26th globally Expertscape in CLL.
  • Chief Editor for Blood Cancer Frontiers in Hematol.
  • Editorial roles at Leukemia & Lymphoma, Cancers, Lymphatics, BMC Medicine, Hematology Reports.
Research

You can view Professor Molica's research on ORCID here.